Ocugen Inc (NAS:OCGN)
$ 0.9501 -0.0074 (-0.77%) Market Cap: 273.49 Mil Enterprise Value: 264.89 Mil PE Ratio: 0 PB Ratio: 13.57 GF Score: 38/100

Q1 2021 Ocugen Inc Earnings Call Transcript

May 07, 2021 / 12:30PM GMT
Release Date Price: $9.19 (-4.12%)
Operator

Good morning and welcome to the Ocugen conference call. At this time, all participants are in listen-only mode.

(Operator Instructions).

Please note this conference is being recorded.

I would now like to turn the conference over to Lisa DeScenza, Vice President of Integrated Communications at LaVoie Health Science to introduce the Ocugen team. You may begin.

Lisa DeScenza
LaVoie Health Science - Vice President of Integrated Communications

Thank you, operator.

I'd like to welcome you to our conference call. With me today are Ocugen's chairman and CEO, Dr. Shankar Musunuri, and our CFO and head of corporate development, Sanjay Subramanian.

Earlier this morning, Ocugen issued a press release, including a business update and first-quarter 2021 financial results. We encourage listeners to review the press release, which is available on the Ocugen website at www.ocugen.com.

This call is also being recorded and a replay will be available on the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot